![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
JM Zgombick, LA Borden, TL Cochran, SA Kucharewicz, RL Weinshank and TA Branchek
Synaptic Pharmaceutical Corporation, Paramus, New Jersey 07652.
The second messenger coupling of cloned human 5-hydroxytryptamine (5- HT)1D alpha and 5-HT1D beta receptors stably expressed in murine fibroblasts (LM (tk-)) was investigated. Clonal cell lines expressing similar receptor densities (Bmax = 750-950 fmol/mg) were used in this study. 5-HT (EC50 = 1.5-2.0 nM) and sumatriptan (EC50 = 6-14 nM), a selective 5-HT1D agonist, produced dose-dependent inhibition of forskolin-stimulated cAMP accumulation in intact cells transfected with the 5-HT1D alpha or 5-HT1D beta receptor gene. The maximal inhibitory responses elicited by these agonists were slightly greater with the 5- HT1D alpha receptor (approximately 90%) than the 5-HT1D beta receptor (approximately 80%). 5-HT (EC50 = 1.7-2.4 nM) and sumatriptan (EC50 = 8- 18 nM) also evoked dose-dependent elevations in intracellular calcium concentrations ([Ca2+]i), with EC50 values that were indistinguishable from those for inhibition of forskolin-stimulated cAMP accumulation. Cells expressing 5-HT1D beta receptors displayed significantly larger 5- HT-induced increases in [Ca2+]i than did cells expressing 5-HT1D alpha receptors (206 nM versus 114 nm increase; p < 0.01). Dose-dependent elevations in inositol phosphates (IP) were also observed after application of 5-HT (EC50 = 29-54 nM) or sumatriptan (EC50 = 73-481 nM); the maximal increases in IP accumulation were modest (51-69%) for both 5-HT1D subtypes. In contrast to the cAMP and calcium responses, the concentration-response curves for IP accumulation were shifted to the right at least 10-fold. Methiothepin, a nonselective 5-HT1 antagonist, competitively antagonized the cAMP response, yielding an apparent dissociation constant (Kb) of 3-4 nM for the 5-HT1D receptors. Methiothepin (10 microM) significantly reduced the elevations in [Ca2+]i (> 90%) and IP (> 75%) evoked by saturating concentrations (1 microM) of agonists. All three functional responses were significantly attenuated (> 90%) by pretreatment with 100 ng/ml pertussis toxin. The sumatriptan-induced elevation of [Ca2+]i via activation of the 5-HT1D subtypes may provide a molecular mechanism of action by which sumatriptan could directly constrict cerebral blood vessels and alleviate migraine symptoms.
This article has been cited by other articles:
|
|
 |
|
  T. Ishida, S. Kawashima, K.-i. Hirata, T. Sakoda, Y. Shimokawa, Y. Miwa, N. Inoue, T. Ueyama, M. Shiomi, H. Akita, et al. Serotonin-Induced Hypercontraction Through 5-Hydroxytryptamine 1B Receptors in Atherosclerotic Rabbit Coronary Arteries Circulation, March 6, 2001; 103(9): 1289 - 1295. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. L. Durham and A. F. Russo Differential Regulation of Mitogen-Activated Protein Kinase-Responsive Genes by the Duration of a Calcium Signal Mol. Endocrinol., October 1, 2000; 14(10): 1570 - 1582. [Abstract] [Full Text]
|
|
|
|
 |
|
 R. Brys, K. Josson, M. P. Castelli, M. Jurzak, P. Lijnen, W. Gommeren, and J. E. Leysen Reconstitution of the Human 5-HT1D Receptor-G-Protein Coupling: Evidence for Constitutive Activity and Multiple Receptor Conformations Mol. Pharmacol., June 1, 2000; 57(6): 1132 - 1141. [Abstract] [Full Text]
|
|
|
|
 |
|
 T. Ishine, I. Bouchelet, E. Hamel, and T. J. F. Lee Serotonin 5-HT7 receptors mediate relaxation of porcine pial veins Am J Physiol Heart Circ Physiol, March 1, 2000; 278(3): H907 - H912. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Pineyro and P. Blier Autoregulation of Serotonin Neurons: Role in Antidepressant Drug Action Pharmacol. Rev., September 1, 1999; 51(3): 533 - 591. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. R. ALBERT, S. J. MORRIS, M. H. GHAHREMANI, J. M. STORRING, and P. M. C. LEMBO A Putative {alpha}-helical G{beta}{gamma}-coupling Domain in the Second Intracellular Loop of the 5-HT1A Receptor Ann. N.Y. Acad. Sci., December 15, 1998; 861(1): 146 - 161. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Adham, J. M. Zgombick, J. Bard, and T. A. Branchek Functional Characterization of the Recombinant Human 5-Hydroxytryptamine7(a) Receptor Isoform Coupled to Adenylate Cyclase Stimulation J. Pharmacol. Exp. Ther., November 1, 1998; 287(2): 508 - 514. [Abstract] [Full Text]
|
|
|
|
 |
|
 L. P. Baker, M. D. Nielsen, S. Impey, M. A. Metcalf, S. W. Poser, G. Chan, K. Obrietan, M. W. Hamblin, and D. R. Storm Stimulation of Type 1 and Type 8 Ca2+/Calmodulin-sensitive Adenylyl Cyclases by the Gs-coupled 5-Hydroxytryptamine Subtype 5-HT7A Receptor J. Biol. Chem., July 10, 1998; 273(28): 17469 - 17476. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. L. Durham and A. F. Russo Serotonergic Repression of Mitogen-Activated Protein Kinase Control of the Calcitonin Gene-Related Peptide Enhancer Mol. Endocrinol., July 1, 1998; 12(7): 1002 - 1009. [Abstract] [Full Text]
|
|
|
|
 |
|
 P. L. Durham, R. V. Sharma, and A. F. Russo Repression of the Calcitonin Gene-Related Peptide Promoter by 5-HT1 Receptor Activation J. Neurosci., December 15, 1997; 17(24): 9545 - 9553. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Movahedi and R. E. Purdy Pharmacological Characterization of the "Silent" 5-Hydroxytryptamine1B-like Receptors of Rabbit Ear Artery J. Pharmacol. Exp. Ther., November 1, 1997; 283(2): 653 - 660. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. A. Moskowitz and C. Waeber Migraine Enters the Molecular Era Neuroscientist, May 1, 1996; 2(3): 191 - 200. [Abstract] [PDF]
|
|
|
|
|
|
C. Gerald, M. W. Walker, P. J.-J. Vaysse, C. He, T. A. Branchek, and R. L. Weinshank Expression Cloning and Pharmacological Characterization of a Human Hippocampal Neuropeptide Y/Peptide YY Y2 Receptor Subtype J. Biol. Chem., November 10, 1995; 270(45): 26758 - 26761. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Bard, M. W. Walker, T. A. Branchek, and R. L. Weinshank Cloning and Functional Expression of a Human Y4 Subtype Receptor for Pancreatic Polypeptide, Neuropeptide Y, and Peptide YY J. Biol. Chem., November 10, 1995; 270(45): 26762 - 26765. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Chiono, R. Mahey, G. Tate, and D. M. F. Cooper Capacitative Ca[IMAGE] Entry Exclusively Inhibits cAMP Synthesis in C6-2B Glioma Cells J. Biol. Chem., January 20, 1995; 270(3): 1149 - 1155. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Wood and A. F. Russo Autoregulation of Cell-specific MAP Kinase Control of the Tryptophan Hydroxylase Promoter J. Biol. Chem., June 8, 2001; 276(24): 21262 - 21271. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
